Abstract: An inflatable curtain having an inflatable portion and a non-inflatable portion is disclosed. First and second stiffening elements are positioned along the upper edge of the inflatable curtain. The inflatable curtain is adapted to be stored within an interior portion of a vehicle prior to inflation. The vehicle has a roof at its highest point, and a housing within the vehicle and close to the roof defines an internal recess that accommodates the inflatable curtain. A side impact of a magnitude greater than a predetermined threshold value is sensed by a sensor mechanism within the vehicle, which then provides an electrical signal to an inflator which is in fluid communication with the inflatable portion of the inflatable curtain. The electrical signal causes the inflator to be actuated in a known manner. The inflator discharges fluid under pressure into the inflatable portion of the inflatable curtain.

Abstract: An inflatable curtain having an inflatable portion and a non-inflatable portion is disclosed. First and second stiffening elements are positioned along the upper edge of the inflatable curtain. The inflatable curtain is adapted to be stored within an interior portion of a vehicle prior to inflation. The vehicle has a roof at its highest point, and a housing within the vehicle and close to the roof defines an internal recess that accommodates the inflatable curtain. A side impact of a magnitude greater than a predetermined threshold value is sensed by a sensor mechanism within the vehicle, which then provides an electrical signal to an inflator which is in fluid communication with the inflatable portion of the inflatable curtain. The electrical signal causes the inflator to be actuated in a known manner. The inflator discharges fluid under pressure into the inflatable portion of the inflatable curtain.

Abstract: New LH-RH antagonists are disclosed, in particular peptidomimetics and peptides modified in a side chain, their salts with pharmaceutically acceptable acids and a process for preparing these LH-RH antagonists and their salts. The disclosed peptides represent analogues of the luteinising hormone releasing hormone (LH-RH). The disclosed compounds have a high antagonistic power and are free of undesirable side effects, in particular edematogenic effects.